相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dysregulation of CalDAG-GEFI and CalDAG-GEFII predicts the severity of motor side-effects induced by anti-parkinsonian therapy
Jill R. Crittenden et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Mitogen- and stress-activated protein kinase-1 deficiency is involved in expanded-huntingtin-induced transcriptional dysregulation and striatal death
Emmanuel Roze et al.
FASEB JOURNAL (2008)
Intrabodies binding the proline-rich domains of mutant huntingtin increase its turnover and reduce neurotoxicity
Amber L. Southwell et al.
JOURNAL OF NEUROSCIENCE (2008)
Novel targets for Huntington's disease in an mTOR-independent autophagy pathway
Andrea Williams et al.
NATURE CHEMICAL BIOLOGY (2008)
Functional roles for the striatal-enriched transcription factor, Bcl11b, in the control of striatal gene expression and transcriptional dysregulation in Huntington's disease
Paula A. Desplats et al.
NEUROBIOLOGY OF DISEASE (2008)
Essential role for Rap1 GTPase and its guanine exchange factor CaIDAG-GEFI in LFA-1 but not VLA-4 integrin-mediated human T-cell adhesion
Haifa Ghandour et al.
BLOOD (2007)
Inhibitors of metabolism rescue cell death in Huntington's disease models
Hemant Varma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage
Alexandre Kuhn et al.
HUMAN MOLECULAR GENETICS (2007)
Mice lacking the signaling molecule CaIDAG-GEFI represent a model for leukocyte adhesion deficiency type III
Wolfgang Bergmeier et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Selective inhibitors of death in mutant huntingtin cells
Hemant Varma et al.
NATURE CHEMICAL BIOLOGY (2007)
Striosomes and mood dysfunction in Huntington's disease
Lynette J. Tippett et al.
BRAIN (2007)
N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease
Mannie M. Y. Fan et al.
PROGRESS IN NEUROBIOLOGY (2007)
Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures
H. Diana Rosas et al.
MOVEMENT DISORDERS (2006)
Huntingtin inclusions do not down-regulate specific genes in the R6/2 Huntington's disease mouse
G. Sadri-Vakili et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Selective deficits in the expression of striatal-enriched mRNAs in Huntington's disease
PA Desplats et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Mutant huntingtin alters MAPK signaling pathways in PC12 and striatal cells: ERK1/2 protects against mutant huntingtin-associated toxicity
BL Apostol et al.
HUMAN MOLECULAR GENETICS (2006)
Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic mice
EC Stack et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2005)
Regional cortical thinning in preclinical Huntington disease and its relationship to cognition
HD Rosas et al.
NEUROLOGY (2005)
A combination drug therapy improves cognition and reverses gene expression changes in a mouse model of Huntington's disease
AJ Morton et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Activation of the IκB kinase complex and nuclear factor-κB contributes to mutant Huntingtin neurotoxicity
A Khoshnan et al.
JOURNAL OF NEUROSCIENCE (2004)
CalDAG-GEFI integrates signaling for platelet aggregation and thrombus formation
JR Crittenden et al.
NATURE MEDICINE (2004)
Deranged neuronal calcium signaling and Huntington disease
I Bezprozvanny et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
A gene expression atlas of the central nervous system based on bacterial artificial chromosomes
SC Gong et al.
NATURE (2003)
Megakaryocytes derived from embryonic stem cells implicate CalDAG-GEFI in integrin signaling
K Eto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain
R Luthi-Carter et al.
HUMAN MOLECULAR GENETICS (2002)
Abnormal phosphorylation of synapsin I predicts a neuronal transmission impairment in the R6/2 Huntington's disease transgenic mice
JC Liévens et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2002)
Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy
B Ravikumar et al.
HUMAN MOLECULAR GENETICS (2002)
Guanine nucleotide exchange factors CalDAG-GEFI and CalDAG-GEFII are colocalized in striatal projection neurons
S Toki et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2001)
A Ca1DAG-GEFI/Rap1/B-Raf cassette couples M1 muscarinic acetylcholine receptors to the activation of ERK1/2
FF Guo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Rap2 as a slowly responding molecular switch in the Rap1 signaling cascade
Y Ohba et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Decreased expression of striatal signaling genes in a mouse model of Huntington's disease
R Luthi-Carter et al.
HUMAN MOLECULAR GENETICS (2000)
Truncated and full-length TrkB receptors regulate distinct modes of dendritic growth
TA Yacoubian et al.
NATURE NEUROSCIENCE (2000)
分享论文
